| scholarly article | Q13442814 |
| P50 | author | Beat A Kaufmann | Q83298510 |
| Jonathan R Lindner | Q89706631 | ||
| P2093 | author name string | Yue Qi | |
| Aris Xie | |||
| Stuart Bunting | |||
| Terry K Morgan | |||
| J Todd Belcik | |||
| Susan P Bagby | |||
| Sherry Bullens | |||
| Ganesh Kolumam | |||
| Jon A Oyer | |||
| Joe Kowalski | |||
| P2860 | cites work | Capillary recruitment in exercise: rate, extent, uniformity, and relation to blood flow | Q71136302 |
| Blockade of VEGF accelerates proteinuria, via decrease in nephrin expression in rat crescentic glomerulonephritis | Q83207457 | ||
| VEGF inhibition and renal thrombotic microangiopathy | Q24632792 | ||
| Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer | Q27860681 | ||
| Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion | Q28263850 | ||
| Vascular recruitment in skeletal muscle during exercise and hyperinsulinemia assessed by contrast ultrasound | Q30308648 | ||
| Relation between myocardial oxygen consumption and myocardial blood volume: a study using myocardial contrast echocardiography | Q30309902 | ||
| Cross-species vascular endothelial growth factor (VEGF)-blocking antibodies completely inhibit the growth of human tumor xenografts and measure the contribution of stromal VEGF. | Q33226862 | ||
| MYOCARDIAL FORCE-VELOCITY RELATIONS STUDIED IN INTACT UNANESTHETIZED MAN. | Q34079143 | ||
| Sunitinib in patients with metastatic renal cell carcinoma | Q34568166 | ||
| Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases | Q34835409 | ||
| Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts | Q35102889 | ||
| Mechanisms of adverse effects of anti-VEGF therapy for cancer | Q36609627 | ||
| Angiotensin II-nitric oxide interaction in the kidney. | Q36672433 | ||
| VEGF-targeted cancer therapy strategies: current progress, hurdles and future prospects | Q36803200 | ||
| Vascular endothelial growth factor receptor 2 controls blood pressure by regulating nitric oxide synthase expression | Q37353319 | ||
| Understanding and managing the possible adverse effects associated with bevacizumab | Q37487406 | ||
| Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure | Q42928039 | ||
| Hypertension Induced by the Tyrosine Kinase Inhibitor Sunitinib Is Associated With Increased Circulating Endothelin-1 Levels | Q42928512 | ||
| Effective arterial elastance as index of arterial vascular load in humans | Q43483026 | ||
| Capillary regression in vascular endothelial growth factor-deficient skeletal muscle. | Q45951692 | ||
| VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature | Q46231250 | ||
| Molecular imaging of endothelial vascular cell adhesion molecule-1 expression and inflammatory cell recruitment during vasculogenesis and ischemia-mediated arteriogenesis | Q47680752 | ||
| Vascular endothelial growth factor/vascular permeability factor produces nitric oxide-dependent hypotension. Evidence for a maintenance role in quiescent adult endothelium. | Q54151586 | ||
| Reversibility of capillary density after discontinuation of bevacizumab treatment | Q57790016 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| microvessel | Q6840468 | ||
| P304 | page(s) | 618-625 | |
| P577 | publication date | 2012-06-13 | |
| P1433 | published in | Journal of the American College of Cardiology | Q2984355 |
| P1476 | title | Cardiovascular and systemic microvascular effects of anti-vascular endothelial growth factor therapy for cancer | |
| P478 | volume | 60 |
| Q42649977 | "On-target" cardiac effects of anticancer drugs: lessons from new biology |
| Q30386954 | Augmentation of limb perfusion and reversal of tissue ischemia produced by ultrasound-mediated microbubble cavitation. |
| Q56991273 | Cardiotoxicity with vascular endothelial growth factor inhibitor therapy |
| Q92508778 | Contrast Enhanced Ultrasound Perfusion Imaging in Skeletal Muscle |
| Q45901060 | Endoglin and activin receptor-like kinase 1 heterozygous mice have a distinct pulmonary and hepatic angiogenic profile and response to anti-VEGF treatment. |
| Q59430751 | Hypertension in cancer patients treated with anti-angiogenic based regimens |
| Q36964256 | Inhibition of pathological retinal neovascularization by semaphorin 3A. |
| Q49568718 | Mechanisms of VEGF (Vascular Endothelial Growth Factor) Inhibitor-Associated Hypertension and Vascular Disease |
| Q64064807 | Mitochondrial dysfunction-mediated decline in angiogenic capacity of endothelial progenitor cells is associated with capillary rarefaction in patients with hypertension via downregulation of CXCR4/JAK2/SIRT5 signaling |
| Q47235398 | Myocardial contrast echocardiography in mice: Technical and physiological aspects. |
| Q50932310 | The Role of Angiogenesis in Cancer Treatment. |
| Q38925714 | The contribution of VEGF signalling to fostamatinib-induced blood pressure elevation |
| Q36428702 | Tumor angiogenesis and anti-angiogenic therapy in malignant gliomas revisited |
| Q90011558 | Vascular Endothelial Growth Factor Delivery to Placental Basal Plate Promotes Uterine Artery Remodeling in the Primate |
Search more.